Science Corp.
Neurotechnology company developing brain implants to treat blindness. Its PRIMA retina implant sits at the back of the e
HealthRaised $230 million Series, bringing valuation to $1.5 billion
About
Neurotechnology company developing brain implants to treat blindness. Its PRIMA retina implant sits at the back of the eye with special glasses to help blind people see, currently under regulatory review in Europe and the US.
Key Facts
Category
Health
Raised
$230 million Series, bringing valuation to $1.5 billion
Discovered via
newsletter:TLDR
Links
Similar products worth knowing
Want products like this in your inbox every morning?
Five products. Every morning. Written by someone who actually cares whether they're good or not. Free forever, unsubscribe whenever.